Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Crocs, Inc. (CROX) vs Erasca Inc. Common Stock (ERAS) Price & Performance

Crocs, Inc.Trade
Erasca Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Crocs, Inc. vs Erasca Inc. Common Stock — how do they compare? Crocs, Inc. trades at $116.68 (market cap $5.53B), while Erasca Inc. Common Stock trades at $15.57 (market cap $4.95B). The key difference: Crocs, Inc. and Erasca Inc. Common Stock are close in size by market cap, and Crocs, Inc. is more actively traded (967,176 versus 3,834,689). Which is the better fit depends on your goals — on Pluang, investors hold Crocs, Inc. for 96 Days and Erasca Inc. Common Stock for 0 Days on average.

CROXERAS
Market Cap
$5.53B$4.95B
Volume
967,1763,834,689
Sector
Consumer CyclicalHealth
52-Week High
$141.19$22.47
52-Week Low
$73.39$2.20
Typical Hold Time
96 Days0 Days
Enterprise Value
$7.04B$4.72B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Crocs, Inc.

Crocs (CROX) trades at $116.84, down 2.81% today, amid bearish technical signals but strong fundamental valuation metrics. The stock shows attractive P/E of 10.23 and P/S of 1.46, with robust profitability margins including 57.47% gross margin and 42.3% ROE. Recent earnings have consistently beaten expectations, with Q2 2026 EPS of $4.55 surpassing the $4.35 estimate. The company maintains strong cash flow generation despite a net loss in 2025, with management focusing on product innovation and HEYDUDE brand repositioning.

CROX presents a compelling value opportunity with discounted valuation multiples relative to historical performance, though near-term technical weakness and competitive pressures warrant caution. Analyst consensus remains bullish with $136.78 price target representing 17% upside potential. Key risks include consumer discretionary spending sensitivity and execution challenges with brand diversification initiatives. The stock's current levels offer entry points for long-term investors seeking exposure to a profitable footwear company with strong brand recognition.

Erasca Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CROX
100% Buy0% Sell
Avg holding period · 96 Days
ERAS
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Crocs, Inc.

Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable geographic segments of the company include Americas, Asia pacific, and EMEA.

Read more on CROX →

About Erasca Inc. Common Stock

Erasca is a biotechnology company developing precision medicines for cancer. Its programs target genetic drivers of tumor growth.

Read more on ERAS →